Caterpillar Moves Formulary Compliance To 70% With Counterdetailing
Caterpillar has increased its formulary compliance rate by 20 percentage points this year based on a counterdetailing effort, Caterpillar Plan Design Manager Richard Wright told an Aug. 27 meeting sponsored by the National Association of Chain Drug Stores meeting.
You may also be interested in...
The RxHealth Value consumer/payor coalition plans to issue a report on the impact of patent extensions on the pharmaceutical market by this summer.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials